Patented drug delivery mechanisms in MiniMist and MiniLiquid through the Breease pacifier, make at-home administration of inhaled medication to infants and children easy – and 4 times more accurate than any other solution. With the direct healthcare cost of asthma in the U.S. alone at 56Bn$ every year, and treatment adherence estimated to be under 10%, risk of under dosage and overdosage of costly medicines, the world needs a solution now.

Treat children more effectively and affordably
MiniMist and MiniLiquid let you deliver exactly the right amount of medicine, to exactly right place and treat illnesses such as asthma and cystic fibrosis. They’re also easier for caregivers to use and non-scary for kids, vitally increasing treatment adherence. That means health outcomes and quality of life for kids go up while the cost of the treatment goes down, improving affordability.